Literature DB >> 25543164

How and why researchers use the number needed to vaccinate to inform decision making--a systematic review.

Ahmed Hashim1, Vica Dang2, Shelly Bolotin3, Natasha S Crowcroft4.   

Abstract

BACKGROUND: The number needed to vaccinate (NNV) is a measure that has been widely used in the scientific literature to draw conclusions about the usefulness and cost-effectiveness of various immunization programmes. The main objective of this review is to examine how and why the NNV has been used and reported in the published literature.
METHODS: Electronic databases were searched and records were screened against the eligibility criteria by two independent authors. We included papers that reported and interpreted NNV.
RESULTS: We identified 27 studies, the designs including observational studies, economic analyses, systematic reviews, and commentaries. The NNV has been used in the literature to describe three main themes: potential benefits of vaccination programmes, cost-effectiveness, and economic analyses, and modelling studies to compare different vaccination strategies.
CONCLUSIONS: NNV has been used in a wide variety of ways in the literature, yet there are no defined thresholds for what is a favourable NNV. Furthermore, the generalizability of the NNV is usually limited. Further work is required to determine the most appropriate use of this measure. Crown
Copyright © 2015. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Benefits of vaccination; Cost-effectiveness; Immunization; Mathematicalmodelling; Number needed to treat; Number needed to vaccinate

Mesh:

Substances:

Year:  2014        PMID: 25543164     DOI: 10.1016/j.vaccine.2014.12.033

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  5 in total

1.  Number Needed to Quarantine and Proportion of Prevented Infectious Days by Quarantine: Evaluating the Effectiveness of COVID-19 Contact Tracing.

Authors:  Diogo Fernandes da Silva; João Vasco Santos; Filipa Santos Martins
Journal:  Public Health Rep       Date:  2022-08-20       Impact factor: 3.117

2.  HBV vaccination and PMTCT as elimination tools in the presence of HIV: insights from a clinical cohort and dynamic model.

Authors:  Anna L McNaughton; José Lourenço; Louise Hattingh; Emily Adland; Samantha Daniels; Anriette Van Zyl; Connie S Akiror; Susan Wareing; Katie Jeffery; M Azim Ansari; Paul Klenerman; Philip J R Goulder; Sunetra Gupta; Pieter Jooste; Philippa C Matthews
Journal:  BMC Med       Date:  2019-02-21       Impact factor: 8.775

3.  The influence of SARS-CoV-2 vaccination on post-operative outcomes in microsurgery patients.

Authors:  Susan M Taghioff; Benjamin R Slavin; Manish Narasimman; Georges Samaha; Mario Samaha; Tripp Holton; Devinder Singh
Journal:  Microsurgery       Date:  2022-07-15       Impact factor: 2.080

4.  The potential population-based impact of an HPV vaccination intervention in Colorado.

Authors:  Jessica R Cataldi; Marian Håbesland; Amy Anderson-Mellies; Amanda F Dempsey; Myles Cockburn
Journal:  Cancer Med       Date:  2019-12-23       Impact factor: 4.452

5.  Examining the potential benefits of the influenza vaccine against SARS-CoV-2: A retrospective cohort analysis of 74,754 patients.

Authors:  Susan M Taghioff; Benjamin R Slavin; Tripp Holton; Devinder Singh
Journal:  PLoS One       Date:  2021-08-03       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.